Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ADMP

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADMP
DateTimeSourceHeadlineSymbolCompany
09/09/202306:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
08/09/202302:00GlobeNewswire Inc.Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic FocusNASDAQ:ADMPAdamis Pharmaceuticals Corporation
02/09/202306:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
30/08/202306:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
22/08/202307:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
21/08/202323:15GlobeNewswire Inc.Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
15/08/202306:38Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ADMPAdamis Pharmaceuticals Corporation
11/08/202306:03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/08/202303:43GlobeNewswire Inc.Adamis Pharmaceuticals Announces Closing of $8.0 Million Public OfferingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
04/08/202306:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
04/08/202306:55Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ADMPAdamis Pharmaceuticals Corporation
02/08/202322:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public OfferingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
02/08/202314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/08/202307:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
29/07/202307:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
29/07/202306:58Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ADMPAdamis Pharmaceuticals Corporation
28/07/202322:30GlobeNewswire Inc.Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid ExpertNASDAQ:ADMPAdamis Pharmaceuticals Corporation
27/07/202320:08Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:ADMPAdamis Pharmaceuticals Corporation
27/07/202311:17Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ADMPAdamis Pharmaceuticals Corporation
25/07/202306:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
25/07/202306:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/07/202306:37Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/06/202321:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces NIH Grant Funding for the Treatment of Alcohol Use DisorderNASDAQ:ADMPAdamis Pharmaceuticals Corporation
22/06/202321:30GlobeNewswire Inc.Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose PreventionNASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/06/202320:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
13/06/202305:22Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
31/05/202308:14Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
27/05/202306:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/05/202306:26GlobeNewswire Inc.Adamis Pharmaceuticals Announces Closing of the Merger with DMK PharmaceuticalsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
23/05/202306:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
 Showing the most relevant articles for your search:NASDAQ:ADMP